FDA Pulls Amputation Boxed Warning Off Canagliflozin Label FDA Pulls Amputation Boxed Warning Off Canagliflozin Label

New safety information suggests the risk of amputation, while still increased with canagliflozin, is lower than previously described, particularly when appropriately monitored, the FDA said.News Alerts
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news